|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
CA2326389C
(en)
|
1998-04-21 |
2007-01-23 |
Micromet Gesellschaft Fur Biomedizinische Forschung Mbh |
Novel cd19xcd3 specific polypeptides and uses thereof
|
|
AU2003264009A1
(en)
|
2002-08-15 |
2004-03-03 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
JP3803790B2
(ja)
|
2003-02-17 |
2006-08-02 |
株式会社東北テクノアーチ |
新規なダイアボディ型二重特異性抗体
|
|
CN100415765C
(zh)
|
2003-08-07 |
2008-09-03 |
宜康公司 |
兔单克隆抗体的人源化方法
|
|
US8076459B2
(en)
|
2003-10-16 |
2011-12-13 |
Micromet Ag |
Multispecfic deimmunized CD3-binders
|
|
SG188175A1
(en)
|
2004-06-03 |
2013-03-28 |
Novimmune Sa |
Anti-cd3 antibodies and methods of use thereof
|
|
JP4902674B2
(ja)
|
2006-03-09 |
2012-03-21 |
エフ.ホフマン−ラ ロシュ アーゲー |
抗薬物抗体アッセイ法
|
|
CA2673470A1
(en)
|
2006-12-21 |
2008-07-03 |
Macrogenics, Inc. |
Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
NZ579594A
(en)
|
2007-03-12 |
2012-03-30 |
Esbatech Alcon Biomed Res Unit |
Sequence based engineering and optimization of single chain antibodies
|
|
WO2008119567A2
(en)
|
2007-04-03 |
2008-10-09 |
Micromet Ag |
Cross-species-specific cd3-epsilon binding domain
|
|
NZ601583A
(en)
|
2007-05-21 |
2013-08-30 |
Bristol Myers Squibb Co |
Novel rabbit antibody humanization methods and humanized rabbit antibodies
|
|
NZ581468A
(en)
|
2007-06-25 |
2012-09-28 |
Esbatech Alcon Biomed Res Unit |
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
CN101688200B
(zh)
|
2007-06-25 |
2012-08-08 |
艾斯巴技术,爱尔康生物医药研究装置有限责任公司 |
单链抗体的基于序列的改造和优化
|
|
PL2307458T3
(pl)
|
2008-06-25 |
2018-08-31 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała
|
|
PL2307455T3
(pl)
|
2008-06-25 |
2017-09-29 |
Esbatech, An Alcon Biomedical Research Unit Llc |
Optymalizacja rozpuszczalności cząsteczek immunowiążących
|
|
KR102391731B1
(ko)
|
2013-01-14 |
2022-04-27 |
젠코어 인코포레이티드 |
신규한 이형이량체 단백질
|
|
EP3587448B1
(en)
|
2013-03-15 |
2021-05-19 |
Xencor, Inc. |
Heterodimeric proteins
|
|
HUE050159T2
(hu)
|
2013-12-17 |
2020-11-30 |
Genentech Inc |
Anti-CD3 antitestek és alkalmazási eljárások
|
|
EP4137816B1
(en)
|
2014-02-11 |
2025-03-19 |
Genzyme Corporation |
Assays for detecting the presence or amount of an anti-drug antibody
|
|
JP6696982B2
(ja)
|
2014-11-26 |
2020-05-20 |
ゼンコー・インコーポレイテッドXencor、 Inc. |
Cd3および腫瘍抗原に結合するヘテロ二量体抗体
|
|
WO2018178307A1
(en)
|
2017-03-31 |
2018-10-04 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
US20190016802A1
(en)
*
|
2017-07-14 |
2019-01-17 |
Immatics Biotechnologies Gmbh |
Dual specificity polypeptide molecule
|
|
KR20200142525A
(ko)
|
2018-04-05 |
2020-12-22 |
노파르티스 아게 |
암에 대한 삼중특이성 결합 분자 및 이의 용도
|
|
KR20220015382A
(ko)
*
|
2019-05-29 |
2022-02-08 |
큐 바이오파마, 인크. |
다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법
|
|
CA3148161A1
(en)
|
2019-09-05 |
2021-03-11 |
Adverum Biotechnologies |
Anti-drug antibody assay
|
|
NL2024375B1
(en)
*
|
2019-12-04 |
2021-08-31 |
Apo T B V |
Methods and means for attracting immune effector cells to tumor cells.
|
|
AU2020402581A1
(en)
*
|
2019-12-11 |
2022-06-23 |
Molecular Partners Ag |
Designed ankyrin repeat domains with altered surface residues
|
|
EP4304726A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Mage-a4 peptide-mhc antigen binding proteins
|
|
US12435444B2
(en)
|
2021-03-09 |
2025-10-07 |
Cdr-Life Ag |
Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
|